REPLY

Affiliations

¹ Divisions of Hepatology and Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada.
² Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
³ Hepato-neuro Laboratory CRCHUM, Université de Montréal, Montréal, Québec, Canada.
⁴ Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Comment

Constantine J Karvellas et al. Hepatology. 2017 Aug.

. 2017 Aug;66(2):670-671.

doi: 10.1002/hep.29194. Epub 2017 Jul 4.

¹ Divisions of Hepatology and Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada.
² Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
³ Hepato-neuro Laboratory CRCHUM, Université de Montréal, Montréal, Québec, Canada.
⁴ Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

No abstract available

Comment on

Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure.
Karvellas CJ, Speiser JL, Tremblay M, Lee WM, Rose CF; US Acute Liver Failure Study Group. Karvellas CJ, et al. Hepatology. 2017 Mar;65(3):938-949. doi: 10.1002/hep.28945. Epub 2017 Jan 19. Hepatology. 2017. PMID: 27859489 Free PMC article.
FABP1 as a novel potential biomarker for predicting mortality in acetaminophen-induced acute liver failure.
Fan H, Zhu JH. Fan H, et al. Hepatology. 2017 Aug;66(2):670. doi: 10.1002/hep.29195. Epub 2017 Jul 4. Hepatology. 2017. PMID: 28370205 No abstract available.